Production technologies for monoclonal antibodies and their fragments

被引:107
作者
Andersen, DC [1 ]
Reilly, DE [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.copbio.2004.08.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, monoclonal antibodies have emerged as an increasingly important class of human therapeutics. A variety of forms of antibodies, including fragments such as Fabs, Fab'(2)s and single-chain Fvs, are also being evaluated for a range of different purposes. A variety of expression systems and improvements within these systems have been developed to address these growing and diverse needs.
引用
收藏
页码:456 / 462
页数:7
相关论文
共 70 条
[1]  
ADLRICH TL, 2003, BIOTECHNOL PROGR, V19, P1433
[2]   Decoupling cell growth and product formation in Chinese hamster ovary cells through metabolic control [J].
Altamirano, C ;
Cairó, JJ ;
Gòdia, F .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 76 (04) :351-360
[3]   Recombinant protein expression for therapeutic applications [J].
Andersen, DC ;
Krummen, L .
CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (02) :117-123
[4]  
ARVAHAL AV, 2003, BIOTECHNOL PROGR, V19, P69
[5]   High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein [J].
Bailey, CG ;
Tait, AS ;
Sunstrom, NA .
BIOTECHNOLOGY AND BIOENGINEERING, 2002, 80 (06) :670-676
[6]   Galactose-extended glycans of antibodies produced by transgenic plants [J].
Bakker, H ;
Bardor, M ;
Molthoff, JW ;
Gomord, V ;
Elbers, I ;
Stevens, LH ;
Jordi, W ;
Lommen, A ;
Faye, L ;
Lerouge, P ;
Bosch, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2899-2904
[7]   Stability of protein production from recombinant mammalian cells [J].
Barnes, LM ;
Bentley, CM ;
Dickson, AJ .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 81 (06) :631-639
[8]   Uncoupling of cell growth and proliferation results in enhancement of productivity in p21C1P1-arrested CHO cells [J].
Bi, JX ;
Shuttleworth, J ;
Ai-Rubeai, M .
BIOTECHNOLOGY AND BIOENGINEERING, 2004, 85 (07) :741-749
[9]   High-level expression of full-length antibodies using trans-complementing expression vectors [J].
Bianchi, AA ;
McGrew, JT .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 84 (04) :439-444
[10]  
Borth N, 2000, BIOTECHNOL BIOENG, V71, P266, DOI 10.1002/1097-0290(2000)71:4<266::AID-BIT1016>3.0.CO